WARSAW, Ind., Oct. 21, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting bold innovations across its ...

ZBH's Q3 results on Nov. 5 may show solid gains, driven by hip, knee, and S.E.T. segment growth and recent product approvals.

Biocomposites’ spacers for knee, hip, and shoulder revision surgeries are loaded with antibiotics to mitigate the risk of ...

Zimmer Biomet has completed its $177 million acquisition of Monogram Technologies, an orthopedic robotics company.  The acquisition expands Zimmer’s suite of orthopedic robotics by adding Monogram’s ...

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.

Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...

Zimmer Biomet (NYSE: ZBH) announced yesterday that it launched two new solutions for complex foot and ankle trauma.